Endometrial Neoplasms is an active area of clinical research and therapeutic development covered by The Life Science Feed. Our editorial team tracks the latest clinical trials, treatment guidelines, regulatory updates, and scientific advances relevant to Endometrial Neoplasms. Browse the latest articles below for in-depth analysis and evidence-based clinical insights.
Immunotherapy Reshapes First-Line Treatment for Advanced Endometrial Cancer
Adding pembrolizumab to chemotherapy significantly improved progression-free survival in advanced or recurrent endometrial cancer, regardless of mismatch repair status. These findings support updated first-line treatment guidelines.
Dostarlimab Plus Chemotherapy Extends Progression-Free Survival in Advanced Endometrial Cancer
Adding dostarlimab to carboplatin-paclitaxel chemotherapy significantly improved progression-free survival in patients with primary advanced or recurrent endometrial cancer, particularly in those with mismatch repair-deficient tumors. This Phase 3 trial hig...
• Aug 28 – 31ERS 2026 • Barcelona, ES 
• Sep 5 – 9EASD 2026 • Milan, IT 
• Sep 28 – Oct 2UEG Week 2026 • Vienna, AT 
• Oct 3 – 7Joint ACTRIMS-ECTRIMS 2026 • Toronto, CA 
• Oct 21 – 23ESMO 2026 • Madrid, ES • Oct 23 – 27AHA 2026 • Chicago, US 
• Nov 7 – 9ACR 2026 • Washington DC, US • Nov 14 – 19ASH 2026 • New Orleans, US • Dec 12 – 15ACC.27 Together With WCC • Houston, US • Apr 10 – 12ESC 2026 • Munich, DE • Aug 28 – 31ERS 2026 • Barcelona, ES • Sep 5 – 9EASD 2026 • Milan, IT • Sep 28 – Oct 2UEG Week 2026 • Vienna, AT • Oct 3 – 7Joint ACTRIMS-ECTRIMS 2026 • Toronto, CA • Oct 21 – 23ESMO 2026 • Madrid, ES • Oct 23 – 27AHA 2026 • Chicago, US • Nov 7 – 9ACR 2026 • Washington DC, US • Nov 14 – 19ASH 2026 • New Orleans, US • Dec 12 – 15ACC.27 Together With WCC • Houston, US • Apr 10 – 12